SCHEMBL30656361

SCHEMBL30656361

COC(=O)c1c(C(=O)N(C)OC)sc2ccc(Br)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 6/20 0.46
ATM Q13315 3/20 0.46
TLR9 Q9NR96 1/20 0.46
TDP1 Q9NUW8 3/20 0.46
CLK1 P49759 2/20 0.42
DYRK1A Q13627 1/20 0.42
DYRK1B Q9Y463 1/20 0.42
UBE2N P61088 1/20 0.41
PFKFB3 Q16875 1/20 0.40
PFKFB4 Q16877 1/20 0.40
TSHR P16473 2/20 0.40
HTT P42858 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NR4A2 P43354 1/20 0.39
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26661116 1.00 LMNA (0.47) LMNAMAPK1L3MBTL1ATMTLR9
SCHEMBL26661107 0.85 LMNA (0.63) LMNAMAPK1L3MBTL1ATMTLR9
SCHEMBL31351348 0.85 LMNA (0.63) LMNAMAPK1L3MBTL1ATMTLR9
SCHEMBL30656383 0.83 LMNA (0.52) LMNAMAPK1L3MBTL1ATMTLR9
SCHEMBL26661127 0.83 LMNA (0.52) LMNAMAPK1L3MBTL1ATMTLR9
SCHEMBL26661110 0.78 LMNA (0.52) LMNAMAPK1L3MBTL1ATMTLR9
SCHEMBL10958206 0.74 PFKFB3 (0.54) LMNAMAPK1L3MBTL1ATMTDP1
SCHEMBL20563093 0.74 MAPT (0.48) LMNAMAPK1L3MBTL1ATMTDP1
SCHEMBL30656385 0.74 L3MBTL1 (0.44) LMNAMAPK1L3MBTL1ATMTLR9
SCHEMBL26661118 0.74 L3MBTL1 (0.44) LMNAMAPK1L3MBTL1ATMTLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP disclosed
CN-119421879-A Novel derivatives for the treatment of TRPM3 mediated disorders 勒芬天主教大学 2025-02-11 CN disclosed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed